This is the first renewal of the T32 application from Division of Pediatric Cardiology, Vanderbilt University School of Medicine. By advancing a program that integrates formal training in research on developmental determinants of cardiovascular disease with clinical training in pediatric cardiology, we will provide a unique training environment that will foster development of academic pediatric cardiologists. This training program will not only focus on the molecular and genetic etiologies of congenital heart disease, but will also emphasize the impact of pre- and postnatal development in defining the manifestations of cardiovascular pathology after birth. In addition to trainees in the Pediatric Cardiology, clinical or Ph.D. post-doctoral fellows who have an expressed interest in investigating development mechanisms of cardiovascular disease will be eligible for support. We are requesting continued support for 3 trainees / year for two years for a total of 6 trainees / year for a five year period. This program will provide a unique opportunity for trainees to study the recapitulation of normal developmental processes in the ontogeny of cardiovascular pathology presenting later in childhood or adulthood. The program will be composed of two tracks optimized either for pursuit of preparation for (1) basic science investigation or (2) clinical or translational research. A focused, mentored, laboratory experience with targeted didactic interactions will be tailored to meet the needs of those pursing a more basic science career. For trainees pursuing a career in clinical or translational medicine, the Vanderbilt Master of Science in Clinical Investigation (MSCI) program will be an integral part of the training program. Candidates will be identified from the pool of applicants applying for a pediatric cardiology fellowship (112 applicants for 3 positions in 2017) as well as from talented clinical and post-doctoral fellows throughout Vanderbilt University. During a first clinical year of pediatric cardiology fellowship (PGY-4) the candidates will be matched with mentors and together, they will decide upon a research project. During the second and third years of a four year fellowship, trainees will carry out a mentored research project. During the fourth year, the trainee will complete clinical training with the option of advanced training in a sub-subspecialty as well as continued research and submission of a K08 or K23 application. This grant will provide support for the second and third years of protected research training. The Department of Pediatrics is committed to complete support of fellows during the first and fourth years as well as supplementing support provided by this grant in years two and three. Using the unique strengths of Vanderbilt University in the areas of cardiac development and regeneration, myocardial biology, pulmonary biology and pulmonary hypertension, cardiovascular genetics and pharmacogenomics, vascular biology and atherosclerosis, as well as cardiovascular outcomes based research and bioinformatics, the program will help train the next generation of physician scientists focused on pediatric cardiovascular disease.

Public Health Relevance

(Relevance) This proposal builds upon the past record of the Division of Pediatric Cardiology at Vanderbilt in training academic pediatric cardiologists, and in particular, upon a successful program integrating 2 years (partially funded by this training grant) of mentored research training including an MSCI degree, with 2 years of clinical training (to be funded by the Division of Pediatric Cardiology and the Department of Pediatrics). With a theme of investigating developmental determinants of cardiovascular disease, this program will be essential in ensuring the continued success of training the next generation of physician-scientists who can carry out research in pediatric cardiovascular disease and apply this new knowledge to the care of children and young adults with congenital and acquired heart disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Scott, Jane
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
United States
Zip Code
La Porta, Silvia; Roth, Lise; Singhal, Mahak et al. (2018) Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis. J Clin Invest 128:834-845
O'Connor, Amy M; Smith, Andrew H; Crum, Kim et al. (2018) Analysis of clinical and candidate genetic risk factors for postoperative atrial tachycardia after congenital heart surgery in infants. Am Heart J 202:1-4
Raucci Jr, Frank J; Parra, David A; Christensen, Jason T et al. (2017) Synthetic hematocrit derived from the longitudinal relaxation of blood can lead to clinically significant errors in measurement of extracellular volume fraction in pediatric and young adult patients. J Cardiovasc Magn Reson 19:58
Angel, Peggi M; Baldwin, H Scott; Gottlieb Sen, Danielle et al. (2017) Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve. Biochim Biophys Acta Proteins Proteom 1865:927-935
Soslow, Jonathan H; Markham, Larry W; Burnette, W Bryan et al. (2017) Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores. Front Pharmacol 8:914
Mouledoux, J; Guerra, S; Ballweg, J et al. (2017) A novel, more efficient, staged approach for critical congenital heart disease screening. J Perinatol 37:288-290
Wells, Quinn S; Veatch, Olivia J; Fessel, Joshua P et al. (2017) Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults. Pharmacogenet Genomics 27:247-254
Nixon, Benjamin R; Williams, Alexandra F; Glennon, Michael S et al. (2017) Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development. JCI Insight 2:e90656
Angel, P M; Narmoneva, D A; Sewell-Loftin, M K et al. (2017) Proteomic Alterations Associated with Biomechanical Dysfunction are Early Processes in the Emilin1 Deficient Mouse Model of Aortic Valve Disease. Ann Biomed Eng 45:2548-2562
McKane, Meghann; Soslow, Jonathan H; Xu, Meng et al. (2017) Does Body Mass Index Predict Premature Cardiomyopathy Onset for Duchenne Muscular Dystrophy? J Child Neurol 32:499-504

Showing the most recent 10 out of 29 publications